TOG, no because the profits are increased by the tax advantages.
30Mil$ profit for instances = 30Mil$ cash (and not 20Mil$) as long as PPHM has tax advantages. That is 165Mil$ set aside for R&D OR the equivalent of 33% of ALL THEY SPEND ON R&D in their EXISTENCE!
And that is ONLY the extra cash from tax advantages. The 67% other profits remain also.
The PPHM has lowered R&D spending tremendously with NCCN and MSK, etc. And Avid grows and Exosomes will become a very important source of early revenue. AIMO.
Market Data 
Markets 
AI
